TUB-030

About Tubulis Technologies

Tubulis Technologies is a private, clinical-stage biotech developing next-generation antibody-drug conjugates (ADCs) through its proprietary technology platforms. The company has advanced two in-house programs into clinical trials for solid tumors and is building a broader pipeline. With a strong scientific foundation and leadership team, Tubulis aims to overcome traditional ADC limitations, such as stability and payload scope, to create more effective and durable cancer therapies.

Therapeutic Areas